CJC-1295 (No DAC) & Ipamorelin Blend – 5mg / 5mg

CJC-1295 (No DAC) + Ipamorelin 5mg/5mg Research Blend

This research blend contains CJC-1295 without DAC and Ipamorelin, supplied exclusively for laboratory and in vitro investigation.

CJC-1295 without DAC is associated with GHRH-receptor research, while Ipamorelin is investigated as a growth-hormone-secretagogue-receptor agonist. The blend is relevant to comparative receptor-signalling and endocrine-pathway models.

Published investigations remain experimental and do not establish suitability, safety or effectiveness for human or veterinary use.

Product-specific analytical documentation is published through the Product Documentation section where it is currently available. Documentation availability may vary between products and batches.

Research Areas

• GHRH-receptor signalling research
• GHSR-associated pathway studies
• Comparative peptide-receptor investigations
• Endocrine-signalling research
• Multi-peptide interaction models

Product Information

• Contents: CJC-1295 (No DAC) 5mg and Ipamorelin 5mg
• Total peptide content: 10mg
• Format: Research blend

Important Research Use Notice

This product is supplied strictly for laboratory and in vitro research purposes only.
Not for human consumption.
Not for veterinary use.
Not for medical, therapeutic, diagnostic or administration purposes.